Skip to content
Screener

Total Liabilities at other companies

Baxter International logo
Baxter InternationalBAX
$62M-99.6%
Revvity logo
RevvityRVTY
$4.81B+1.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$116.09B+1.0%
Utah Medical Products logo
Utah Medical ProductsUTMD
$4.01M-26.7%
Medtronic logo
MedtronicMDT
$42.96B-1.1%
Organon logo
OrganonOGN
$12.09B-4.1%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$14.6B+7.4%
Enterprise value$17.52B+9.5%
P/E61.9×+28.6×
P/S3.5×+0.1×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.

Filed
Jun 5, 2026, 4:47 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-041305
Line itemApril 30, 2026October 31, 2025
Long-term tax payable5.67.5
Deferred revenue208.8201.8
Other liabilities266.4282.8
Total liabilities4,243.24,155.7
Contingencies and commitments (Note 9)
Stockholders’ equity:
Preferred stock, $0.10 par value, 1.0 shares authorized, zero shares issued or outstanding
Common stock, $0.10 par value, 480.0 shares authorized, 217.9 issued and 194.9 outstanding at April 30, 2026, and 217.6 issued and 195.9 outstanding at October 31, 202521.821.8

Item 1. Unaudited Financial Statements

FAQ

What is The Cooper Companies, Inc.'s total liabilities?
The Cooper Companies, Inc. (COO) reported total liabilities of $4.24B in Q1 2026.
How has The Cooper Companies, Inc.'s total liabilities changed year-over-year?
The Cooper Companies, Inc.'s total liabilities increased by 2.9% year-over-year, from $4.13B to $4.24B.
What is the long-term trend for The Cooper Companies, Inc.'s total liabilities?
Over 5 years (2020 to 2025), The Cooper Companies, Inc.'s total liabilities has grown at a 7.4% compound annual growth rate (CAGR), from $2.91B to $4.16B.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about The Cooper Companies, Inc.'s total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude